"The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend
Although Part D beneficiaries are eligible, patients who receive GLP-1s through Bridge will not have those fills covered by Medicare Part D
A licensed provider reviews your medical history, current medications, and goals to determine whether treatment is appropriate and to set a safe plan
Prevalence and Age: What the Numbers Tell Us ED prevalence climbs with age, driven by cumulative vascular risk, hormonal shifts, medication burden, and chronic disease
Over time, it causes fewer dark spots, melasma, and hyperpigmentation, resulting in a lighter, more even-looking skin tone
It works by mimicking the GLP-1 hormone your body naturally produces to help control blood sugar levels